SPY394.11-14.21 -3.48%
DIA317.31-9.79 -2.99%
IXIC11,487.93-496.60 -4.14%

--Goldman Sachs Adjusts Price Target for Eli Lilly and Company to $270 From $264, Maintains Neutral Rating

MT Newswires · 04/29/2022 08:18

Please log in to view news